GYENNO SCIENCE

In this study, the quantitative assessment of non-motor symptoms of Parkinson's disease (hallucinations) was realized through VR.
Matrix Pro developed by GYENNO Science utilized machine vision and multiple fusion perceptual technologies in combination with artificial intelligence algorithms to intelligently quantify motor symptoms on the MDS-UPDRS III classic scale.

Numerosity estimation of virtual humans as a digital-robotic marker for hallucinations in Parkinson’s disease - Nature Communications Virtual reality, robotics and digital online technologies reveal heightened visual overestimation when estimating the number of humans, indexing presence hallucinations in healthy participants and patients with Parkinson’s disease.

AI technology has the potential to transform early detection and assessment of many diseases.

Parkinson's disease could be detected early with AI scans, scientists say The study detected physical differences in the eyes of people with Parkinson's and those without the condition.

It's important to adjust a positive mindset as much as possible to slow the progression of Parkinson's disease through training and maintaining good communication with your doctor about your treatment!

A Pianist Adapts to Life With Parkinson’s Disease In the fall of 2018, the pianist Nicolas Hodges noticed his body shaking. He brought it up at a routine doctor’s appointment in Tübingen, Germany, where he

More than 60% of Parkinson's disease patients are diagnosed with high blood pressure.
Scientists from China analysed two years of clinical results using data from the Parkinson's Disease Progression Marker Initiative (PDPMI).

Parkinson's progression not affected by blood pressure... More than 60% of Parkinson's disease patients are diagnosed with high blood pressure, leading researchers to explore a possible connection.

Connecticut researchers uncover regulator compound with potential to treat Parkinson's disease

Connecticut researchers uncover regulator compound with potential to treat Parkinson's disease: Report An assistant professor at UConn Health and a team of researchers have reportedly discovered a regulator compound which hold the potential to treat Parkinson's disease.

Beyond Reward, Dopamine Drives Movement

Beyond Reward, Dopamine Drives Movement - Neuroscience News Researchers discovered a genetic subtype of dopamine neurons that fires during movement, contrary to the long-standing belief that dopamine neurons primarily respond to rewards.